344 related articles for article (PubMed ID: 32939676)
1. De novo ARHGEF9 missense variants associated with neurodevelopmental disorder in females: expanding the genotypic and phenotypic spectrum of ARHGEF9 disease in females.
Scala M; Zonneveld-Huijssoon E; Brienza M; Mecarelli O; van der Hout AH; Zambrelli E; Turner K; Zara F; Peron A; Vignoli A; Striano P
Neurogenetics; 2021 Mar; 22(1):87-94. PubMed ID: 32939676
[TBL] [Abstract][Full Text] [Related]
2. ARHGEF9 mutations in epileptic encephalopathy/intellectual disability: toward understanding the mechanism underlying phenotypic variation.
Wang JY; Zhou P; Wang J; Tang B; Su T; Liu XR; Li BM; Meng H; Shi YW; Yi YH; He N; Liao WP
Neurogenetics; 2018 Jan; 19(1):9-16. PubMed ID: 29130122
[TBL] [Abstract][Full Text] [Related]
3. Autism spectrum disorder in females with ARHGEF9 alterations and a random pattern of X chromosome inactivation.
Aarabi M; Kessler E; Madan-Khetarpal S; Surti U; Bellissimo D; Rajkovic A; Yatsenko SA
Eur J Med Genet; 2019 Apr; 62(4):239-242. PubMed ID: 30048823
[TBL] [Abstract][Full Text] [Related]
4. A novel
Qiu T; Dai Q; Wang Q
J Int Med Res; 2021 Nov; 49(11):3000605211058372. PubMed ID: 34851771
[No Abstract] [Full Text] [Related]
5. Xq11.1-11.2 deletion involving ARHGEF9 in a girl with autism spectrum disorder.
Bhat G; LaGrave D; Millson A; Herriges J; Lamb AN; Matalon R
Eur J Med Genet; 2016 Sep; 59(9):470-3. PubMed ID: 27238888
[TBL] [Abstract][Full Text] [Related]
6. The phenotypic spectrum of ARHGEF9 includes intellectual disability, focal epilepsy and febrile seizures.
Klein KM; Pendziwiat M; Eilam A; Gilad R; Blatt I; Rosenow F; Kanaan M; Helbig I; Afawi Z;
J Neurol; 2017 Jul; 264(7):1421-1425. PubMed ID: 28620718
[TBL] [Abstract][Full Text] [Related]
7. Loss-of-function variants in ARHGEF9 are associated with an X-linked intellectual disability dominant disorder.
Ghesh L; Besnard T; Nizon M; Trochu E; Landeau-Trottier G; Breheret F; Thauvin-Robinet C; Bruel AL; Kuentz P; Coubes C; Cuisset L; Mignot C; Keren B; Bézieau S; Cogné B
Hum Mutat; 2021 May; 42(5):498-505. PubMed ID: 33600053
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Molecular Characterization of Three Novel ARHGEF9 Mutations in Patients with Developmental Delay and Epilepsy.
Yao R; Zhang Y; Liu J; Wang J; Xu Y; Li N; Wang J; Yu T
J Mol Neurosci; 2020 Jun; 70(6):908-915. PubMed ID: 31942680
[TBL] [Abstract][Full Text] [Related]
9. De novo Xq11.11 microdeletion including ARHGEF9 in a boy with mental retardation, epilepsy, macrosomia, and dysmorphic features.
Lesca G; Till M; Labalme A; Vallee D; Hugonenq C; Philip N; Edery P; Sanlaville D
Am J Med Genet A; 2011 Jul; 155A(7):1706-11. PubMed ID: 21626670
[TBL] [Abstract][Full Text] [Related]
10. ARHGEF9 gene variant leads to developmental and epileptic encephalopathy: Genotypic phenotype analysis and treatment exploration.
Yang H; Liao H; Gan S; Xiao T; Wu L
Mol Genet Genomic Med; 2022 Jul; 10(7):e1967. PubMed ID: 35638461
[TBL] [Abstract][Full Text] [Related]
11. Human ARHGEF9 intellectual disability syndrome is phenocopied by a mutation that disrupts collybistin binding to the GABA
Hines DJ; Contreras A; Garcia B; Barker JS; Boren AJ; Moufawad El Achkar C; Moss SJ; Hines RM
Mol Psychiatry; 2022 Mar; 27(3):1729-1741. PubMed ID: 35169261
[TBL] [Abstract][Full Text] [Related]
12. De novo variants in CNOT9 cause a neurodevelopmental disorder with or without epilepsy.
von Wintzingerode L; Ben-Zeev B; Cesario C; Chan KM; Depienne C; Elpeleg O; Iascone M; Kelley WV; Nassogne MC; Niceta M; Pezzani L; Rahner N; Revencu N; Bekheirnia MR; Santiago-Sim T; Tartaglia M; Thompson ML; Trivisano M; Hentschel J; Sticht H; Abou Jamra R; Oppermann H
Genet Med; 2023 Jul; 25(7):100859. PubMed ID: 37092538
[TBL] [Abstract][Full Text] [Related]
13. De novo variants in SP9 cause a novel form of interneuronopathy characterized by intellectual disability, autism spectrum disorder, and epilepsy with variable expressivity.
Tessarech M; Friocourt G; Marguet F; Lecointre M; Le Mao M; Díaz RM; Mignot C; Keren B; Héron B; De Bie C; Van Gassen K; Loisel D; Delorme B; Syrbe S; Klabunde-Cherwon A; Jamra RA; Wegler M; Callewaert B; Dheedene A; Zidane-Marinnes M; Guichet A; Bris C; Van Bogaert P; Biquard F; Lenaers G; Marcorelles P; Ferec C; Gonzalez B; Procaccio V; Vitobello A; Bonneau D; Laquerriere A; Khiati S; Colin E
Genet Med; 2024 May; 26(5):101087. PubMed ID: 38288683
[TBL] [Abstract][Full Text] [Related]
14. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
Mol Autism; 2019; 10():35. PubMed ID: 31649809
[TBL] [Abstract][Full Text] [Related]
15. PCDH19-related epilepsy is associated with a broad neurodevelopmental spectrum.
Smith L; Singhal N; El Achkar CM; Truglio G; Rosen Sheidley B; Sullivan J; Poduri A
Epilepsia; 2018 Mar; 59(3):679-689. PubMed ID: 29377098
[TBL] [Abstract][Full Text] [Related]
16. Variant-specific effects define the phenotypic spectrum of HNRNPH2-associated neurodevelopmental disorders in males.
Kreienkamp HJ; Wagner M; Weigand H; McConkie-Rossell A; McDonald M; Keren B; Mignot C; Gauthier J; Soucy JF; Michaud JL; Dumas M; Smith R; Löbel U; Hempel M; Kubisch C; Denecke J; Campeau PM; Bain JM; Lessel D
Hum Genet; 2022 Feb; 141(2):257-272. PubMed ID: 34907471
[TBL] [Abstract][Full Text] [Related]
17. Monoallelic and bi-allelic variants in NCDN cause neurodevelopmental delay, intellectual disability, and epilepsy.
Fatima A; Hoeber J; Schuster J; Koshimizu E; Maya-Gonzalez C; Keren B; Mignot C; Akram T; Ali Z; Miyatake S; Tanigawa J; Koike T; Kato M; Murakami Y; Abdullah U; Ali MA; Fadoul R; Laan L; Castillejo-López C; Liik M; Jin Z; Birnir B; Matsumoto N; Baig SM; Klar J; Dahl N
Am J Hum Genet; 2021 Apr; 108(4):739-748. PubMed ID: 33711248
[TBL] [Abstract][Full Text] [Related]
18. Next-generation phenotyping using computer vision algorithms in rare genomic neurodevelopmental disorders.
van der Donk R; Jansen S; Schuurs-Hoeijmakers JHM; Koolen DA; Goltstein LCMJ; Hoischen A; Brunner HG; Kemmeren P; Nellåker C; Vissers LELM; de Vries BBA; Hehir-Kwa JY
Genet Med; 2019 Aug; 21(8):1719-1725. PubMed ID: 30568311
[TBL] [Abstract][Full Text] [Related]
19. De novo missense variants in HECW2 are associated with neurodevelopmental delay and hypotonia.
Berko ER; Cho MT; Eng C; Shao Y; Sweetser DA; Waxler J; Robin NH; Brewer F; Donkervoort S; Mohassel P; Bönnemann CG; Bialer M; Moore C; Wolfe LA; Tifft CJ; Shen Y; Retterer K; Millan F; Chung WK
J Med Genet; 2017 Feb; 54(2):84-86. PubMed ID: 27389779
[TBL] [Abstract][Full Text] [Related]
20. Missense and truncating variants in CHD5 in a dominant neurodevelopmental disorder with intellectual disability, behavioral disturbances, and epilepsy.
Parenti I; Lehalle D; Nava C; Torti E; Leitão E; Person R; Mizuguchi T; Matsumoto N; Kato M; Nakamura K; de Man SA; Cope H; Shashi V; ; Friedman J; Joset P; Steindl K; Rauch A; Muffels I; van Hasselt PM; Petit F; Smol T; Le Guyader G; Bilan F; Sorlin A; Vitobello A; Philippe C; van de Laar IMBH; van Slegtenhorst MA; Campeau PM; Au PYB; Nakashima M; Saitsu H; Yamamoto T; Nomura Y; Louie RJ; Lyons MJ; Dobson A; Plomp AS; Motazacker MM; Kaiser FJ; Timberlake AT; Fuchs SA; Depienne C; Mignot C
Hum Genet; 2021 Jul; 140(7):1109-1120. PubMed ID: 33944996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
